发布: 2014年07月20日第4卷第14期 DOI: 10.21769/BioProtoc.1181 浏览次数: 12005
评审: Anonymous reviewer(s)
Abstract
Human mesenchymal stem/progenitor cells (MSCs) isolated from various adult tissues show remarkable therapeutic potential and are being employed in clinical trials for the treatment of numerous diseases (Prockop et al., 2010). While routes of cell administration vary, profound beneficial effects of MSCs in animal models have been observed following intraperitoneal injections of the cells (Roddy et al., 2011). Similar to MSC spheres formed in culture under conditions where attachment to plastic is not permitted (Bartosh et al., 2010), MSCs injected into the peritoneum of mice spontaneously aggregate into 3D sphere-like structures (Bartosh et al., 2013). During the process of sphere assembly and compaction, MSCs upregulate expression of numerous therapeutic anti-inflammatory and immune modulatory factors. Here we describe the method we previously used for the generation of human bone marrow-derived MSC aggregates/spheres in vivo (Bartosh et al., 2013). By tagging the MSCs with green fluorescent protein (GFP), the aggregates formed can be easily visualized, collected and analyzed for changes in cellular properties and interactions with host immune cells.
Keywords: MSCs (骨髓间充质干细胞)Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2014 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Bartosh, T. J. and Ylostalo, J. H. (2014). Mesenchymal Stem Cell (MSC) Aggregate Formation in vivo. Bio-protocol 4(14): e1181. DOI: 10.21769/BioProtoc.1181.
分类
干细胞 > 成体干细胞 > 间充质干细胞
干细胞 > 成体干细胞 > 维持和分化
细胞生物学 > 细胞分离和培养 > 3D细胞培养
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link